malondialdehyde has been researched along with piplartine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borjihan, G; Ma, CJ | 1 |
| An, J; Geng, S; Li, J; Liu, Y; Lv, W; Wu, X; Zhang, Y | 1 |
2 other study(ies) available for malondialdehyde and piplartine
| Article | Year |
|---|---|
[Antiatherogenic effect of piperlonguminine on experimental atherosclerosis in rabbits].
Topics: Animals; Atherosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dioxolanes; Male; Malondialdehyde; Nitric Oxide; Rabbits; Superoxide Dismutase; Triglycerides | 2008 |
Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cell Differentiation; Cell Movement; Cell Proliferation; Dioxolanes; Extracellular Matrix; Fibroblasts; Fibrosis; Heart; Humans; Malondialdehyde; MAP Kinase Signaling System; Myofibroblasts; Phosphorylation; Piper; Rats; Reactive Oxygen Species | 2018 |